Product Wiki · Recalls · Health Canada — Medical Devices

LIAISON Estradiol II Gen (2016-07-13) — recall 55580

Health Canada — Medical Devices · Canada · 2016-07-29 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
55580
Date of alert
2016-07-29
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Notice status
Archived by the issuing authority — kept for reference
Reported risk: The drug fulvestrant (Faslodex) has recently been shown to cross-react with estradiol leading to falsely elevated test results in estradiol assays.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/liaison-estradiol-ii-gen-2016-

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.